Patent US1534211A successfully refreshed from Google Patents.
Patent US4774245A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4774245A Expired / Lapsed US ⏱️ 0.0 years remaining

Imidazoquinoxaline compounds

Assignee: Novo Nordisk AS
•
Filing: 1986-09-26
•
Granted: 1988-09-27
•
Expires: 2006-09-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract New heterocyclic compounds having the general formula ##STR1## wherein X is ##STR2## wherein R 1 is C 1-6 -alkyl, Cphd 3-7-cycloalkyl, phenyl, thienyl, or C 1-3 -alkoxymethyl, R 6 and R 7 independently are hydrogen or halogen, and --A--is --N(R")--C(O)--, --N(R")--CH 2 --, or ##STR3## wherein R" is hydrogen, C 3 ∂ -cycloalkyl, or C 1-6 -alkyl The compounds are useful in psychopharmaceutical preparations as anticonvulsants, anxiolytics, hypnotics, and nootropics.

Inventors

  • 👤 Frank Watjen
  • 👤 Mogens Engelstoft

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 21:58
CPC Classifications
C; C07; C07D; C07D487/00; C07D487/02; C07D487/04; A; A61; A61P; A61P25/00; A61P25/08; A61P25/20; A61P33/00; A61P33/10; C07D487/12; C07D487/14; C07D513/00; C07D513/02; C07D513/04

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 55 words
Heterocyclic quinoxaline compounds having formula I ##STR20## wherein X is ##STR21## wherein R' is C 1-6 -alkyl, C 3-7 -cycloalkyl, phenyl, thienyl, or C 1-3 -alkoxymethyl, R 6 and R 7 independently are hydrogen or halogen, and --A-- is --N(R")--C(O)-- or --N(R")--CH 2 -- wherein R" is hydrogen, C 3-7 -cyclopropyl, or C 1-6 -alkyl.
Claim 2
Dependent Claim 55 words
Heterocyclic quinoxaline compounds having formula I ##STR20## wherein X is ##STR21## wherein R' is C 1-6 -alkyl, C 3-7 -cycloalkyl, phenyl, thienyl, or C 1-3 -alkoxymethyl, R 6 and R 7 independently are hydrogen or halogen, and --A-- is --N(R")--C(O)-- or --N(R")--CH 2 -- wherein R" is hydrogen, C 3-7 -cyclopropyl, or C 1-6 -alkyl.
Claim 3
Dependent Claim 9 words
A compound of claim 1 which is 3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-4,5-dihydro-5-methyl-4-oxo- imidazo(1,5-a)quinoxaline
Claim 4
Dependent Claim 48 words
A pharmaceutical composition suitable for use in the treatment of a central nervous system ailment selected from convulsion and anxiety comprising an amount of a compound of a compound of claim 1 which is effective for the alleviation of such disorder together with a pharmaceutically-acceptable carrier or diluent.
Claim 5
Dependent Claim 22 words
A pharmaceutical composition according to claim 3 in the form of an oral dosage unit containing 1-100 mg of the active compound.
Claim 6
Dependent Claim 47 words
A method of treating a central nervous system ailment in a subject in need of such treatment comprising the step of administering to said subject an amount af a compound of claim 1 which is effective for the alleviation of such ailment selected from convulsion and anxiety.
Claim 7
Dependent Claim 67 words
A method of treating a central nervous system ailment selected from convulsion and anxiety in a subject in need of such treatment comprising the step of administering to said subject an amount of a compound of claim 1 which is effective for the alleviation of such ailment in the form af a pharmaceutical composition thereof, in which it is present together with a pharmaceutically-acceptable carrier or diluent.
Claim 8
Dependent Claim 9 words
A compound of claim 1 which is 3-(3-cyclopropyl-1,2,4-oxadiazol-5-yl)-4,5-dihydro-5-methyl-6-chloro-4-oxo-imidazo (1,5-a)quinoxaline.
Claim 9
Dependent Claim 9 words
A compound of claim 1 which is 3-(5-cyclopropyl-1,2,4-oxadiazol-3-yl)-4,5-dihydro-4-oxo-5-methyl-imidazo (1,5-a)quinoxaline.
Claim 10
Dependent Claim 9 words
A compound of claim 1 which is 3-(3-methoxymethyl-1,2,4-oxadiazol-5-yl)-4,5-dihydro-5-methyl-4-oxo-imidazo (1,5-a)quinoxaline.

References Cited (Backward Citations)

US4440929A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-09-27 1992-03-28 1992-09-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-09-27 1996-03-28 1996-09-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-09-27 2000-03-28 2000-09-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag